| Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study T Güngör, P Teira, M Slatter, G Stussi, P Stepensky, D Moshous, ... The Lancet 383 (9915), 436-448, 2014 | 350 | 2014 |
| The BET bromodomain inhibitor OTX015 affects pathogenetic pathways in preclinical B-cell tumor models and synergizes with targeted drugs M Boi, E Gaudio, P Bonetti, I Kwee, E Bernasconi, C Tarantelli, A Rinaldi, ... Clinical Cancer Research 21 (7), 1628-1638, 2015 | 316 | 2015 |
| Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma V Spina, A Bruscaggin, A Cuccaro, M Martini, M Di Trani, G Forestieri, ... Blood, The Journal of the American Society of Hematology 131 (22), 2413-2425, 2018 | 273 | 2018 |
| Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation A Tichelli, C Bucher, A Rovó, G Stussi, M Stern, M Paulussen, J Halter, ... Blood, The Journal of the American Society of Hematology 110 (9), 3463-3471, 2007 | 260 | 2007 |
| Isotype‐specific detection of ABO blood group antibodies using a novel flow cytometric method G Stussi, K Huggel, HU Lutz, U Schanz, R Rieben, JD Seebach British journal of haematology 130 (6), 954-963, 2005 | 190 | 2005 |
| ABO blood group barrier in allogeneic bone marrow transplantation revisited JD Seebach, G Stussi, JR Passweg, FR Loberiza Jr, JL Gajewski, ... Biology of Blood and Marrow Transplantation 11 (12), 1006-1013, 2005 | 157 | 2005 |
| Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation G Stussi, J Muntwyler, JR Passweg, L Seebach, U Schanz, J Gmür, ... Bone marrow transplantation 30 (2), 87-93, 2002 | 140 | 2002 |
| International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia A Condoluci, L Terzi di Bergamo, P Langerbeins, MA Hoechstetter, ... Blood, The Journal of the American Society of Hematology 135 (21), 1859-1869, 2020 | 132 | 2020 |
| Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia K Zeidler, K Arn, O Senn, U Schanz, G Stussi Transfusion 51 (11), 2269-2276, 2011 | 129 | 2011 |
| Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti … G Stussi, J Halter, E Bucheli, PV Valli, L Seebach, J Gmür, A Gratwohl, ... haematologica 94 (2), 239, 2009 | 114 | 2009 |
| PQR309 is a novel dual PI3K/mTOR inhibitor with preclinical antitumor activity in lymphomas as a single agent and in combination therapy C Tarantelli, E Gaudio, AJ Arribas, I Kwee, P Hillmann, A Rinaldi, ... Clinical Cancer Research 24 (1), 120-129, 2018 | 111 | 2018 |
| Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants MT Martinez, CH Bucher, G Stussi, D Heim, A Buser, DA Tsakiris, ... Bone marrow transplantation 36 (11), 993-1000, 2005 | 111 | 2005 |
| Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy … MD Berger, B Gerber, K Arn, O Senn, U Schanz, G Stussi Haematologica 97 (1), 116, 2012 | 108 | 2012 |
| HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells P Forte, L Pazmany, UB Matter-Reissmann, G Stussi, MKJ Schneider, ... The Journal of Immunology 167 (10), 6002-6008, 2001 | 100 | 2001 |
| Palliative care utilization in oncology and hemato-oncology: a systematic review of cognitive barriers and facilitators from the perspective of healthcare professionals, adult … M Bennardi, N Diviani, C Gamondi, G Stüssi, P Saletti, I Cinesi, ... BMC palliative care 19, 1-17, 2020 | 94 | 2020 |
| Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole B Gerber, R Guggenberger, D Fasler, G Nair, MG Manz, G Stussi, ... Blood, The Journal of the American Society of Hematology 120 (12), 2390-2394, 2012 | 91 | 2012 |
| Reactivity of human natural antibodies to endothelial cells from Galα (1, 3) Gal-deficient pigs BC Baumann, G Stussi, K Huggel, R Rieben, JD Seebach Transplantation 83 (2), 193-201, 2007 | 83 | 2007 |
| Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT R Benz, U Schanz, M Maggiorini, JD Seebach, G Stussi Bone marrow transplantation 49 (1), 62-65, 2014 | 82 | 2014 |
| Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology … GJ Ossenkoppele, G Stussi, J Maertens, K van Montfort, BJ Biemond, ... Blood, The Journal of the American Society of Hematology 120 (24), 4706-4711, 2012 | 79 | 2012 |
| Changes of circulating antibody levels induced by ABO antibody adsorption for ABO-incompatible kidney transplantation PV Valli, GP Yung, T Fehr, C Schulz-Huotari, N Kaup, T Güngör, ... American journal of transplantation 9 (5), 1072-1080, 2009 | 64 | 2009 |
